Evidence map›Paper›PMID 41268761›Full record

ArticleOrthopaedic surgery2026

Core Decompression Combined With Superselective Intra-Arterial Perfusion for Osteonecrosis of the Femoral Head: Prognostic Factor-Driven Analysis of Efficacy.

Li Qian, Qianhong Jian, Yinghong Ma, Yue Zhai, Jiaxin Dong, Xianbing Huang, Yao Fang

Abstract read
In one paragraph

Article in Orthopaedic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Hip Arthroscopy With Triangular Drilling and Suction Decompression for Osteonecrosis of the Femoral Head: A Retrospective Study.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Li QianDepartment of Pain Medicine, Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, China.ORCID https://orcid.org/0000-0002-8167-7288
Qianhong JianDepartment of Pain Medicine, Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, China.
Yinghong MaDepartment of Pain Medicine, Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, China.
Yue ZhaiDepartment of Pain Medicine, Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, China.
Jiaxin DongDepartment of Pain Medicine, Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, China.
Xianbing HuangDepartment of Pain Medicine, Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, China.
Yao FangDepartment of Pain Medicine, Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, China.

Funding

2024 Central Government Subsidy Funds for Healthcare Service and Assurance Capacity Improvement (Healthcare Institution Capacity Building) Qian Cai She [2023]-186Guizhou Province Scientific and Technological Achievements Transformation and Industrialization Program Project in 2025 (Clinical Special Program) Qian-Ke-He Achievements LC[2025]-039
6 · The paper itself

Abstract

backgroundOsteonecrosis of the femoral head (ONFH) is a progressive and disabling disease that commonly affects young and middle-aged adults. Without timely treatment, it often progresses to femoral head collapse and hip dysfunction, ultimately requiring total hip arthroplasty. Although core decompression (CD) and superselective intra-arterial perfusion have been applied clinically, their long-term efficacy as monotherapy remains limited, and the clinical value of combining these approaches has not been fully clarified.

objectivesThis study aimed to evaluate the clinical efficacy of CD combined with superselective intra-arterial perfusion in the treatment of ONFH, and to identify key prognostic factors influencing therapeutic outcomes.

methodsThis study enrolled 145 patients in the CD group, 123 in the SIAE group, and 89 in the combined group. Preoperative baseline characteristics, postoperative Harris Hip Scores (HHS), Visual Analog Scale (VAS) scores, MRI-derived collapse rates, and complication rates were compared. Patients were stratified into effective and non-effective groups to analyze risk factors. Receiver operating characteristic (ROC) curves assessed predictive performance.

resultsBaseline characteristics, including sex, age, body mass index (BMI), Association Research Circulation Osseous (ARCO) staging, etiology, and lesion location, showed no intergroup differences. The combined group exhibited superior postoperative HHS improvement, VAS reduction, and collapse rate mitigation compared to monotherapy groups. Complication rates were lowest in the combined group (2.2%) versus CD (7.6%) and SIAE (12.2%) groups. The combined group had the highest efficacy rate, with non-traumatic etiology and marginal necrosis predominating in the effective group. Logistic regression identified surgical approach, BMI, etiology, and lesion location as independent predictors of efficacy. Surgical approach demonstrated the highest predictive power (area under the curve (AUC) = 0.7838, sensitivity 83.75%, specificity 60.41%), while the constant term achieved optimal performance (AUC = 0.8549).

conclusionCD combined with SIAE significantly enhances clinical outcomes, alleviates pain, reduces collapse rates, and minimizes complications in ONFH. Surgical approach, BMI, etiology, and lesion location critically influence efficacy. The combined strategy represents a superior intervention with promising clinical applicability.

Indexed as

Decompression, SurgicalFemur Head NecrosisAdultCombined Modality TherapyFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesTreatment Outcomecombined therapycore decompressionosteonecrosis of the femoral headpostoperative complicationsuperselective intra‐arterial embolization

Identifiers

PMID41268761
PMCPMC12796970

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.